For instance, some reports have shown that LDH expression and activity are increased in KRAS mutated lung cancers (McCleland et al., 2013; Xie et al., 2014) and increased GLUT expression in KRAS mutated cells that amplified glycolysis rate in pancreatic cancer (Bryant et al., 2014). This evidence concerns the gene KRAS and lung carcinoma.